IN THIS ISSUE
Legislation & Regulation
John Carroll

Tim Elenz

The Affordable Care Act had brokers thinking they would lose business. Now they are working with private exchanges and adapting in other ways.
Medication Management
Thomas Reinke

Gillian Woollett, MA, DPhil, PhD

How insurers react to the first biosimilars will be crucial to the development of that industry in the United States
The Formulary Files
Krishna Rutvij Patel, PharmD
Tomorrow's Medicine
Thomas Morrow, MD
Breakthrough drugs for fighting cancer race toward approval, but the ubiquitous question persists: How can we afford them?